Related Experiment Video
Updated: Jan 29, 2026

Measuring Endoreduplication by Flow Cytometry of Isolated Tuber Protoplasts
Published on: March 9, 2018
Primary ocular presentation of tuberous sclerosis - A case report
Nancy M Rajasekaran1, Saban Horo1, Thomas Kuriakose1
1Department of Ophthalmology, Christian Medical College, Vellore, Tamil Nadu, India.
Tuberous sclerosis can manifest with abnormal retinal vascularization and exudation, impacting vision. Prompt diagnosis and intravitreal bevacizumab treatment improved visual acuity and ocular findings in a young patient.
Area of Science:
- Ophthalmology
- Neurology
- Genetics
Background:
- Tuberous sclerosis complex (TSC) is a genetic disorder causing tumors in various organs.
- Ocular manifestations of TSC can include retinal abnormalities, though they are often underdiagnosed.
- Early identification of ocular signs is crucial for timely management and preventing vision loss.
Observation:
- A 25-year-old male presented with decreased vision in his left eye.
- Ophthalmic examination revealed a hypopigmented elevated subretinal lesion over the optic disc with abnormal vasculature, hemorrhages, and macular fluid.
- B-scan ultrasonography showed a high spike over the disc with orbital shadowing, and fluorescein angiography confirmed abnormal retinal vasculature.
Findings:
- Systemic evaluation revealed characteristic features of tuberous sclerosis, including facial angiofibroma, ashleaf spots, dental pits, and intracranial tubers on CT scan.
- Intravitreal injection of bevacizumab was administered for the ocular findings.
- The patient showed significant visual and tomographic improvement following treatment.
Implications:
- This case highlights that abnormal retinal vascularization and exudation can be a presenting ocular feature of tuberous sclerosis in young individuals.
- Ophthalmologists should consider TSC in the differential diagnosis of unexplained retinal vascular abnormalities, especially in the presence of suggestive systemic signs.
- Intravitreal anti-VEGF therapy, such as bevacizumab, may be an effective treatment option for managing ocular manifestations of TSC.
Related Concept Videos
Self-Presentation
Self-Presentation: Self-Monitoring and Self-Handicapping
Strategies of Self-Presentation I: Strategic Self-Presentation
Processes of Self-Presentation
Strategies of Self-Presentation II: Self-Verification
Data Reporting and Recording

